Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Relationship Between Cognitive Behavioral Therapy and Post-Traumatic Growth: A Systematic Review.

Healthcare (Basel, Switzerland)·2026
Same author

Letter to the Editor: Circadian and microbial misalignment in metabolic dysfunction-associated steatotic liver disease - mechanistic insights and chronotherapeutic potential.

World journal of experimental medicine·2026
Same author

Letter to the Editor: Endocrine determinants of diabetic ketoacidosis outcomes in type 2 diabetes and insights into Gymnema sylvestre actions.

World journal of experimental medicine·2026
Same author

Melatonin supplementation, hyperprolactinemia, and incident heart failure: A proposed prolactin-mediated pathway for cardiovascular risk.

World journal of experimental medicine·2026
Same author

Circulating Novel Adipokines in Critically Ill Patients with and Without Sepsis.

Biomedicines·2026
Same author

Sleep and Circadian Rhythms in Patients with Physical and Mental Disorders.

Journal of clinical medicine·2026

Related Experiment Videos

Pheochromocytoma: physiopathologic implications and diagnostic evaluation.

Evangelia Zapanti1, Ioannis Ilias

  • 1First Department of Endocrinology, Alexandra hospital, Athens, GR-11528, Greece. liazapanti@yahoo.gr

Annals of the New York Academy of Sciences
|December 29, 2006
PubMed
Summary

Pheochromocytoma (PHEO) is a neural crest tumor. This review covers PHEO's effects and how nuclear medicine, particularly PET imaging with specific tracers, aids in its functional localization.

Related Experiment Videos

Area of Science:

  • Endocrinology
  • Nuclear Medicine
  • Oncology

Background:

  • Pheochromocytoma (PHEO) originates from neural crest chromaffin cells.
  • PHEO predominantly secretes catecholamines (noradrenaline, adrenaline, dopamine) and neuropeptides.
  • These secretions can cause systemic effects and characteristic clinical syndromes.

Purpose of the Study:

  • To review the pathophysiologic implications of PHEO, both intra-adrenal and extra-adrenal.
  • To highlight nuclear medicine modalities for functional imaging and tumor localization.
  • To discuss the development of positron emission tomography (PET) tracers based on catecholamine pathways.

Main Methods:

  • Review of intra-adrenal and extra-adrenal pathophysiologic implications of PHEO.
  • Focus on nuclear medicine modalities for functional imaging.
  • Discussion of PET imaging tracers including [(18)F]-fluorodopamine, [(18)F]-fluorohydroxyphenylalanine, [(11)C]-epinephrine, and [(11)C]-hydroxyephedrine.

Main Results:

  • Functional imaging with PET offers insights into physiological processes.
  • PET tracers can be developed based on catecholamine synthesis and metabolism pathways.
  • Nuclear medicine modalities complement traditional anatomical imaging.

Conclusions:

  • Nuclear medicine, especially PET, is crucial for PHEO functional imaging and localization.
  • Understanding catecholamine pathways enables the development of targeted PET tracers.
  • Functional imaging enhances diagnostic capabilities for PHEO and paragangliomas.